BCL2L1 and breast cancer: Further validating this finding in a panel of breast cancer cell lines, we confirmed that BRD-810 sensitivity strongly correlated with the BCL2L1:BAK expression ratio using mRNA or protein quantification (Extended Data Fig. 3a,b).